Lilly bags Retevmo FDA approval for RET-driven lung and thyroid cancers

pharmanewsdaily- May 9, 2020 0

Retevmo FDA approval : Eli Lilly and Company (Lilly) has secured approval from the US Food and Drug Administration (FDA) for Retevmo (selpercatinib, 40mg and ... Read More

Y-mAbs begins roll-out of BLA of naxitamab to FDA for neuroblastoma

pharmanewsdaily- December 2, 2019 0

US biopharma company Y-mAbs Therapeutics has submitted the first portions of its biologics license application (BLA) for naxitamab to the US Food and Drug Administration ... Read More